This activity is supported by educational grants from Bristol Myers Squibb and Pfizer Alliance Grant.
This program is intended for cardiologists, primary care physicians, physician assistants, nurse practitioners, and other healthcare professionals who care for patients with nonvalvular atrial fibrillation.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Keith C. Ferdinand, MD, FACC, FAHA, has disclosed that he has received consulting fees from Amgen, Boehringer Ingelheim, Medtronic, Novartis, and Sanofi.
David S. Kountz, MD, has no relevant conflicts of interest to report.
Laura Ross, PA-C, CLS, has no relevant conflicts of interest to report.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
This program has been made available online.